JESÚS
HERMOSILLA FERNÁNDEZ
Investigador en el període 2023-2023
Publicacions (11) Publicacions de JESÚS HERMOSILLA FERNÁNDEZ
2024
-
Comprehensive physicochemical and functional analysis of pembrolizumab based on controlled degradation studies: Impact on antigen–antibody binding
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 194, pp. 131-147
2023
-
Analysing the In-Use Stability of mRNA-LNP COVID-19 Vaccines Comirnaty™ (Pfizer) and Spikevax™ (Moderna): A Comparative Study of the Particulate
Vaccines, Vol. 11, Núm. 11
-
Comprehensive physicochemical characterization of a peptide-based medicine: Teduglutide (Revestive®) structural description and stress testing
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 184, pp. 103-115
2022
-
Combined use of UV and MS data for ICH Stability-Indication Method: Quantification and isoforms identification of intact nivolumab
Microchemical Journal, Vol. 182
-
Comprehensive Analysis of Nivolumab, A Therapeutic Anti-Pd-1 Monoclonal Antibody: Impact of Handling and Stress
Pharmaceutics, Vol. 14, Núm. 4
-
Tracking the physicochemical stability of teduglutide (Revestive®) clinical solutions over time in different storage containers
Journal of Pharmaceutical and Biomedical Analysis, Vol. 221
2021
-
Stability study over time of clinical solutions of ziv-aflibercept prepared in infusion bags using a proper combination of physicochemical and functional strategies
Journal of Pharmaceutical and Biomedical Analysis, Vol. 203
-
The relevance of monoclonal antibodies in the treatment of COVID-19
Vaccines, Vol. 9, Núm. 6
2020
-
Comprehensive biophysical and functional study of ziv-aflibercept: characterization and forced degradation
Scientific Reports, Vol. 10, Núm. 1
-
Use of subcutaneous tocilizumab to prepare intravenous solutions for COVID-19 emergency shortage: Comparative analytical study of physicochemical quality attributes
Journal of Pharmaceutical Analysis, Vol. 10, Núm. 6, pp. 532-545